ACRO BIOMEDICAL CO., LTD. Annual Cost of Revenue in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Acro Biomedical Co., Ltd. quarterly/annual Cost of Revenue history and growth rate from 2017 to 2022.
  • Acro Biomedical Co., Ltd. Cost of Revenue for the quarter ending June 30, 2023 was $0.000.
  • Acro Biomedical Co., Ltd. Cost of Revenue for the twelve months ending June 30, 2023 was $296K, a 55.8% decline year-over-year.
  • Acro Biomedical Co., Ltd. annual Cost of Revenue for 2022 was $518K, a 44.8% decline from 2021.
  • Acro Biomedical Co., Ltd. annual Cost of Revenue for 2021 was $938K, a 77.5% increase from 2020.
  • Acro Biomedical Co., Ltd. annual Cost of Revenue for 2020 was $529K, a 191% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $518K -$420K -44.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-07-21
2021 $938K +$409K +77.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-07-21
2020 $529K +$347K +191% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $181K -$7M -97.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-02
2018 $7.18M +$6.72M +1465% Oct 1, 2017 Sep 30, 2018 10-KT 2020-03-27
2017 $459K Oct 1, 2016 Sep 30, 2017 10-K 2018-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.